You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Zimberelimab

Showing 1 - 25 of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cervical Cancer Trial (Zimberelimab, Platinum, radiotherapy)

Not yet recruiting
  • Cervical Cancer
  • Zimberelimab
  • +2 more
  • (no location specified)
Nov 9, 2023

Locally Advanced Pancreatic Cancer Trial (Stereotactic body radiation(SBRT), Zimberelimab (GLS-010))

Not yet recruiting
  • Locally Advanced Pancreatic Cancer
  • Stereotactic body radiation(SBRT)
  • Zimberelimab (GLS-010)
  • (no location specified)
Aug 22, 2023

Locally Advanced Cervical Cancer Trial in Xi'an (Zimberelimab, Albumin-bound Paclitaxel, Cisplatin)

Recruiting
  • Locally Advanced Cervical Cancer
  • Zimberelimab
  • +2 more
  • Xi'an, Shaanxi, China
    Hongxi Zhao
Sep 20, 2023

Ovarian Clear Cell Carcinoma Trial (Zimberelimab, Metformin Hydrochloride)

Not yet recruiting
  • Ovarian Clear Cell Carcinoma
  • Zimberelimab
  • Metformin Hydrochloride
  • (no location specified)
Feb 25, 2023

Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)

Not yet recruiting
  • Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
  • Guangzhou, Guangdong, China
    Sun Yat-sen University
Oct 24, 2023

Hepatobiliary Cancer, Liver Cancer Trial (Zimberelimab, Domvanalimab)

Not yet recruiting
  • Hepatobiliary Cancer
  • Liver Cancer
  • (no location specified)
Feb 2, 2023

Classical Hodgkin Lymphoma Trial in Guangzhou (Zimberelimab 240mg)

Recruiting
  • Classical Hodgkin Lymphoma
  • Zimberelimab 240mg
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-Sen University Cancer Ce
Jun 15, 2023

Cervical Cancer, Cervical Carcinoma Trial in Guangzhou (Zimberelimab, Lenvatinib)

Not yet recruiting
  • Cervical Cancer
  • Cervical Carcinoma
  • Guangzhou, China
    Sun Yat-sen University Cancer Cetntre
Apr 9, 2023

Triple Negative Breast Cancer Trial in Guangzhou (Chidamide combined with Zimberelimab)

Recruiting
  • Triple Negative Breast Cancer
  • Chidamide combined with Zimberelimab
  • Guangzhou, Guangdong, China
    Sun Yat-sen University, Cancer Center
Nov 20, 2022

Biliary Tract Carcinoma, Cholangiocarcinoma, Bile Duct Cancer Trial in Madison (Gemcitabine, Cisplatin, Zimberelimab)

Not yet recruiting
  • Biliary Tract Carcinoma
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin
Sep 15, 2023

Cervical Cancer Trial in Suzhou (Chemoradiotherapy + Adjuvant chemo and Zimberelimab, Chemoradiotherapy (small pelvic) +

Recruiting
  • Cervical Cancer
  • Chemoradiotherapy + Adjuvant chemotherapy and Zimberelimab
  • Chemoradiotherapy (small pelvic) + Zimberelimab
  • Suzhou, Jiangsu, China
    The Affiliated Suzhou Hospital of Nanjing Medical University
May 14, 2023

Cervical Cancer Trial in China (Disitamab Vedotin, Zimberelimab)

Not yet recruiting
  • Cervical Cancer
  • Disitamab Vedotin
  • Zimberelimab
  • Bengbu, Anhui, China
  • +11 more
Nov 23, 2023

Urothelial Carcinoma, Metastatic Cancer Trial in Houston (Pemetrexed, Zimberelimab, Etrumadenant)

Not yet recruiting
  • Urothelial Carcinoma
  • Metastatic Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Nov 28, 2022

Locally Advanced Cervical Cancer Trial in Shanghai (zimberelimab combined With concurrent radiotherapy and chemo)

Recruiting
  • Locally Advanced Cervical Cancer
  • zimberelimab combined With concurrent radiotherapy and chemotherapy
  • Shanghai, Shanghai, China
    Shanghai Zhongshan hospital
Jun 28, 2022

Melanoma Trial in Pittsburgh (Zimberelimab, Domvanalimab)

Recruiting
  • Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Apr 11, 2022

NSCLC Trial (Zimberelimab, Domvanalimab, Pembrolizumab)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Zimberelimab
  • +7 more
  • (no location specified)
Aug 12, 2022

Non Small Cell Lung Cancer, Non-small Cell Carcinoma, NSCLC Trial in Saint Louis (Zimberelimab, Domvanalimab, Etrumadenant)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Zimberelimab
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 8, 2022

Urothelial Bladder Carcinoma Trial in Spain (Sacituzumab govitecan, Zimberelimab, Domvanalimab)

Not yet recruiting
  • Urothelial Bladder Carcinoma
  • Sacituzumab govitecan
  • +2 more
  • Santiago De Compostela, A Coruña, Spain
  • +9 more
Nov 14, 2023

Dedifferentiated Liposarcoma, Soft Tissue Sarcoma, Sarcoma,Soft Tissue Trial in United States (Etrumadenant, Zimberelimab)

Recruiting
  • Dedifferentiated Liposarcoma
  • +6 more
  • Basking Ridge, New Jersey
  • +6 more
May 23, 2023

Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in United States (SRF617, etrumadenant, zimberelimab)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Prostate Cancer
  • Miami, Florida
  • +6 more
Jun 13, 2022

Advanced Cancer Trial (AB801, Zimberelimab, Docetaxel)

Not yet recruiting
  • Advanced Cancer
  • (no location specified)
Nov 1, 2023

Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma Trial in Los Angeles

Not yet recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • Locally Advanced Pancreatic Ductal Adenocarcinoma
  • Biospecimen Collection
  • +9 more
  • Los Angeles, California
    Yonemoto,Lisa
Jan 13, 2023

Solid Tumors Trial (GS-9911, Zimberelimab)

Not yet recruiting
  • Solid Tumors
  • (no location specified)
Oct 9, 2023

Oligometastatic Prostate Cancer Trial in New York (Quemliclustat, Etrumadenant, Zimberelimab)

Not yet recruiting
  • Oligometastatic Prostate Cancer
  • New York, New York
    Columbia University Irving Medical Center / NewYork-Presbyterian
Jun 14, 2023

Advanced Upper Gastrointestinal Tract Adenocarcinoma Trial in United States (Zimberelimab, Domvanalimab, Nivolumab)

Recruiting
  • Advanced Upper Gastrointestinal Tract Adenocarcinoma
  • Zimberelimab
  • +6 more
  • Hot Springs, Arkansas
  • +11 more
Dec 6, 2022